Company Monitoring Page for Anthera

latest headlines for company on cafepharma

Anthera sees 64% of its value wiped off as CF candidate flunks phase 3 test
Fierce Biotech
Wed, 12/28/16 - 07:34 pm
Tags:
Anthera, clinical trials, cystic fibrosis, Sollpura
Anthera shares slump after lupus trial failure
BioPharma Dive
Sat, 11/12/16 - 09:06 am
Tags:
Anthera, lupus, blisibimod
Two Drugs, Designed To Help Patients, Actually Hurt Them
TheStreet.com
Tue, 11/19/13 - 12:28 pm
Tags:
Vical, Anthera, varespladib, Allovectin-7
A Promising Future For Anthera's Blisibimod
Seeking Alpha
Sat, 09/28/13 - 11:04 am
Tags:
lupus, blisibimod, Anthera
Anthera Pharmaceuticals announces 1-for-8 reverse stock split
Yahoo/the fly on the wall
Sat, 07/13/13 - 12:31 pm
Tags:
Anthera
Anthera Pharmaceuticals Announces Receipt of Nasdaq Notice
Yahoo/PR NewsWire
Sat, 06/22/13 - 10:03 am
Tags:
Anthera
Anthera Refinances Existing Debt with New $20 Million Credit Facility and Secures $18.5 Million Committed Equity Financing Facility
Yahoo/PR Newswire
Sat, 04/6/13 - 11:02 am
Tags:
Anthera
Anthera Initiates CHABLIS-SC1 Phase 3 Clinical Study in Lupus with Blisibimod
Yahoo
Thu, 03/28/13 - 08:47 am
Tags:
blisibimod, Anthera, lupus
Anthera Pharmaceuticals Announces Completion of Public Offering of Common Stock
Yahoo
Wed, 01/30/13 - 10:55 am
Tags:
Anthera, stock offering
Anthera Pharmaceuticals Trading Higher On Additional Data; Need For Capital Could Cap Upside
Seeking Alpha
Thu, 11/29/12 - 10:41 am
Tags:
Anthera, lupus, blisibimod
Anthera's Lupus Drug Gets Second Chance After Clinical Trial Disaster
Seeking Alpha
Wed, 11/14/12 - 12:14 pm
Tags:
Anthera, lupus, blisibimod
Anthera announces advancement of blisibimod in Phase 3 development
The Fly on the Wall
Mon, 09/17/12 - 10:09 am
Tags:
blisibimod, Anthera, lupus
4 Reasons To Buy Anthera Pharmaceuticals
Seeking Alpha
Mon, 07/16/12 - 12:04 pm
Tags:
Anthera
Anthera plunges on drug study
Marketwatch
Thu, 06/28/12 - 12:47 pm
Tags:
Anthera, blisibimod, lupus
A Long Shot In The Lupus Market Gains Attention
Seeking Alpha
Sat, 06/16/12 - 01:39 pm
Tags:
lupus, Anthera, blisibimod
22 Biopharma Stocks With Breakout Potential in 2012
Seeking Alpha
Tue, 05/22/12 - 11:25 am
Tags:
Ziopharm, Zalicus, EXACT Sciences, Geron, Lexicon Pharmaceuticals, Nektar, Vical, Celgene, Celsion, ChemoCentryx, Clovis Oncology, Eli Lilly, JNJ, Pfizer, Elan, Biomarin, Biogen Idec, Auxilium, Arqule, Anthera, Acadia, Amicus Therapeutics, Vertex Pharmaceuticals
Will Human Genome End Up Blazing A Trail For Others?
Seeking Alpha
Mon, 04/9/12 - 05:43 pm
Tags:
Human Genome Sciences, GSK, Eli Lilly, Benlysta, Anthera, Immunomedics, lupus
Biotechs Have No Business in This Indication
Motley Fool
Sun, 03/18/12 - 11:23 am
Tags:
Anthera, acute coronary syndrome
Anthera to cut almost half of its workforce
Reuters
Fri, 03/16/12 - 11:38 am
Tags:
layoffs, Anthera
Anthera halts late-stage heart drug trial, shares tank
Reuters
Sat, 03/10/12 - 04:03 pm
Tags:
Anthera, VISTA-16, acute coronary syndrome

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.